AIRMIT ACE
-
dimenhydrinate tablet
Sato Pharmaceutical Co., Ltd.
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
Uses
For the prevention and treatment of the following symptoms associated with motion sickness
■nausea ■vomiting ■dizziness
Warnings
Do not use
■for children under 2 years of age unless directed by a doctor
■this product if you are taking sedatives or tranquilizers, without first consulting your doctor
Ask a doctor before use if you have
■a breathing problem such as emphysema or chronic bronchitis
■glaucoma
■difficulty in urination due to enlargement of the prostate gland
Directions
adults and children 12 years of age and over - oral dosage is 2 to 4 tablets every 4 to 6 hours, not to exceed 16 tablets in 24 hours, or as directed by a doctor
children 6 to under 12 years of age - oral dosage is 1 to 2 tablets every 6 to 8 hours, not to exceed 6 tablets in 24 hours, or as directed by a doctor
children 2 to under 6 years of age - oral dosage is 1 tablet every 6 to 8 hours, not to exceed 3 tablets in 24 hours, or as directed by a doctor
children under 2 years of age - ask a doctor
Inactive ingredients Dibasic calcium phosphate, FD and C Yellow No. 6, hydroxypropyl cellulose, hydroxypropyl starch, lactose, magnesium stearate, mannitol, microcrystalline cellulose, povidone, sugar.
AIRMIT ACE
dimenhydrinate tablet |
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
OTC monograph final | part336 | 03/11/2005 |
Labeler - Sato Pharmaceutical Co., Ltd. (690575642) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Sato Pharmaceutical Co., Ltd. | 715699133 | manufacture, label, pack |
Revised: 01/2012 Sato Pharmaceutical Co., Ltd.